Zinc, a regulator of islet function and glucose homeostasis

Diabetes, Obesity and Metabolism

Volumn 11, Issue SUPPL. 4, 2009, Pages 202-214

  Wijesekara, N ^a   Chimienti, F ^b   Wheeler, M B ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b Mellitech   (France)

Author keywords

Diabetes; Insulin secretion; Pancreatic islets; SLC30A8; Zinc; ZnT8; cells

Indexed keywords

CARRIER PROTEIN; UNCLASSIFIED DRUG; ZINC; ZINC TRANSPORTER; ZINC TRANSPORTER 8; ZRT IRT LIKE PROTEIN;

DISEASE ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; RISK FACTOR; TRANSPORT KINETICS;

ANIMALS; CATION TRANSPORT PROTEINS; DIABETES MELLITUS, TYPE 2; GLUCOSE; HOMEOSTASIS; HUMANS; INSULIN; ISLETS OF LANGERHANS; PANCREAS; ZINC;

EID: 70350331456     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2009.01110.x     Document Type: Review

References (75)

1. Scott DA, Fisher AM. The insulin and the zinc content of normal and diabetic pancreas. J Clin Invest 1938, 17:725-728.
2. Quarterman J, Mills CF, Humphries WR. The reduced secretion of and sensitivity to insulin in zinc-deficient rats. Biochem Biophys Res Commun 1966, 25:354-358.
3. Engelbart K, Kief H. The functional behaviour of zinc and insulin contained in the pancreatic beta-cells of rats. Virchows Arch B Cell Pathol 1970, 4:294-302.
4. Boquist L, Falkmer S, Havu N, Pihl E. Insulin biosynthesis, storage and secretion. Lakartidningen 1968, 65:3603-3607.
5. Ripa S, Ripa R. Zinc and diabetes mellitus. Minerva Med 1995, 86:415-421.
6. Gupta R, Garg VK, Mathur DK, Goyal RK. Oral zinc therapy in diabetic neuropathy. J Assoc Physicians India 1998, 46:939-942.
7. Begin-Heick N, Dalpe-Scott M, Rowe J, Heick HM. Zinc supplementation attenuates insulin secretory activity in pancreatic islets of the ob/ob mouse. Diabetes 1985, 34:179-184.
8. Simon SF, Taylor CG. Dietary zinc supplementation attenuates hyperglycemia in db/db mice. Exp Biol Med 2001, 226:43-51.
9. Tang X, Shay NF. Zinc has an insulin-like effect on glucose transport mediated by phosphoinositol-3-kinase and Akt in 3T3-L1 fibroblasts and adipocytes. J Nutr 2001, 131:1414-1420.
10. Haase H, Maret W. Intracellular zinc fluctuations modulate protein tyrosine phosphatase activity in insulin/insulin-like growth factor-1 signaling. Exp Cell Res 2003, 291:289-298.
11. Zalewski PD, Millard SH, Forbes IJ. Video image analysis of labile zinc in viable pancreatic islet cells using a specific fluorescent probe for zinc. J Histochem Cytochem 1994, 42:877-884.
12. Sherrill JW. Clinical experiences and experiments with protamin-zinc insulin: the potential danger of hypoglycemia. Cal West Med 1938, 49:13-20.
13. Emdin SO, Dodson GG, Cutfield JM, Cutfield SM. Role of zinc in insulin biosynthesis. Diabetologia 1980, 19:174-182.
14. Foster MC, Leapman RD, Li MX, Atwater I. Elemental composition of secretory granules in pancreatic islets of Langerhans. Biophys J 1993, 64:525-532.
15. Ishihara H, Maechler P, Gjinovci A, Herrera PL, Wollheim CB. Islet beta-cell secretion determines glucagon release from neighbouring alpha-cells. Nat Cell Biol 2003, 5:330-335.
16. Sprietsma JE, Schuitemaker GE. Diabetes can be prevented by reducing insulin production. Med Hypotheses 1994, 42:15-23.
17. Kim BJ, Kim YH, Kim S. Zinc as a paracrine effector in pancreatic islet cell death. Diabetes 2000, 49:367-372.
18. Bray TM, Bettger WJ. The physiological role of zinc as an antioxidant. Free Radic Biol Med 1990, 8:281-291.
19. Crouch RK, Gandy S, Patrick J, Reynolds S, Buse MG, Simson JA. Localization of copper-zinc superoxide dismutase in the endocrine pancreas. Exp Mol Pathol 1984, 41:377-383.
20. Yang L, Li H, Yu T. Polymorphisms in metallothionein-1 and -2 genes associated with the risk of type 2 diabetes mellitus and its complications. Am J Physiol Endocrinol Metab 2008, 294:E987-E992.
21. Ohly P, Dohle C, Abel J, Seissler J, Gleichmann H. Zinc sulphate induces metallothionein in pancreatic islets of mice and protects against diabetes induced by multiple low doses of streptozotocin. Diabetologia 2000, 43:1020-1030.
22. Gyulkhandanyan AV, Lu H, Lee SC. Investigation of transport mechanisms and regulation of intracellular Zn2+ in pancreatic alpha-cells. J Biol Chem 2008, 283:10184-10197.
23. Ho E, Quan N, Tsai YH, Lai W, Bray TM. Dietary zinc supplementation inhibits NF kappaB activation and protects against chemically induced diabetes in CD1 mice. Exp Biol Med 2001, 226:103-111.
24. Franklin I, Gromada J, Gjinovci A, Theander S, Wollheim CB. ß-Cell secretory products activate α-cell ATP-dependent potassium channels to inhibit glucagon release. Diabetes 2005, 54:1808-1815.
25. Bloc A, Cens T, Cruz H, Dunant Y. Zinc-induced changes in ionic currents of clonal rat pancreatic ß-cells : activation of ATP-sensitive K+ channels. J Physiol 2000, 529:723-734.
26. Eren E, Arguello JM. Arabidopsis HMA2, a divalent heavy metal-transporting P(IB)-type ATPase, is involved in cytoplasmic Zn2+ homeostasis. Plant Physiol 2004, 136:3712-3723.
27. Sharma R, Rensing C, Rosen BP, Mitra B. The ATP hydrolytic activity of purified ZntA, a Pb(II)/Cd(II)/Zn(II)-translocating ATPase from Escherichia coli. J Biol Chem 2000, 275:3873-3878.
28. Kawachi M, Kobae Y, Mimura T, Maeshima M. Deletion of a histidine-rich loop of AtMTP1, a vacuolar Zn(2+)/H(+) antiporter of Arabidopsis thaliana, stimulates the transport activity. J Biol Chem 2008, 283:8374-8383.
29. Colvin RA, Davis N, Nipper RW, Carter PA. Evidence for a zinc/proton antiporter in rat brain. Neurochem Int 2000, 36:539-547.
30. Ohana E, Segal D, Palty R. A sodium zinc exchange mechanism is mediating extrusion of zinc in mammalian cells. J Biol Chem 2004, 279:4278-4284.
31. Simons TJ. Calcium-dependent zinc efflux in human red blood cells. J Membr Biol 1991, 123:73-82.
32. Koh JY, Choi DW. Zinc toxicity on cultured cortical neurons: involvement of N-methyl-D-aspartate receptors. Neuroscience 1994, 60:1049-1057.
33. Yin HZ, Weiss JH. Zn(2+) permeates Ca(2+) permeable AMPA/kainate channels and triggers selective neural injury. Neuroreport 1995, 6:2553-2556.
34. Vega MT, Villalobos C, Garrido B. Permeation by zinc of bovine chromaffin cell calcium channels: relevance to secretion. Pflugers Arch 1994, 429:231-239.
35. Atar D, Backx PH, Appel MM, Gao WD, Marban E. Excitation-transcription coupling mediated by zinc Influx through voltage-dependent calcium channels. J Biol Chem 1995, 270:2473-2477.
36. Gyulkhandanyan AV, Lee S, Bikopoulos G, Dai F, Wheeler MB. The Zn2+-transporting pathways in pancreatic beta-cells: a role for the L-type voltage-gated Ca2+ channel. J Biol Chem 2006, 281:9361-9372.
37. Guerinot ML. The ZIP family of metal transporters. Biochim Biophys Acta - Biomembr 2000, 1465:190-198.
38. Kambe T, Yamaguchi-Iwai Y, Sasaki R, Nagao M. Overview of mammalian zinc transporters. Cell Mol Life Sci 2004, 61:49-68.
39. Mocchegiani E, Giacconi R, Malavolta M. Zinc signalling and subcellular distribution: emerging targets in type 2 diabetes. Trends Mol Med 2008, 14:419-428.
40. Wang K, Zhou B, Kuo YM, Zemansky J, Gitschier J. A novel member of a zinc transporter family is defective in acrodermatitis enteropathica. Am J Hum Genet 2002, 71:66-73.
41. Chowanadisai W, Lonnerdal B, Kelleher SL. Identification of a mutation in SLC30A2 (ZnT-2) in women with low milk zinc concentration that results in transient neonatal zinc deficiency. J Biol Chem 2006, 281:39699-39707.
42. Devirgiliis C, Zalewski PD, Perozzi G, Murgia C. Zinc fluxes and zinc transporter genes in chronic diseases. Mutat Res 2007, 622:84-93.
43. Liuzzi JP, Aydemir F, Nam H, Knutson MD, Cousins RJ. Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells. Proc Natl Acad Sci 2006, 103:13612-13617.
44. Liuzzi JP, Bobo JA, Lichten LA, Samuelson DA, Cousins RJ. Responsive transporter genes within the murine intestinal-pancreatic axis form a basis of zinc homeostasis. Proc Natl Acad Sci 2004, 101:14355-14360.
45. Gaither LA, Eide DJ. The human ZIP1 transporter mediates zinc uptake in human K562 erythroleukemia cells. J Biol Chem 2001, 276:22258-22264.
46. Wang F, Kim B, Petris MJ, Eide DJ. The mammalian Zip5 protein is a zinc transporter that localizes to the basolateral surface of polarized cells. J Biol Chem 2004, 279:51433-51441.
47. Kaler P, Prasad R. Molecular cloning and functional characterization of novel zinc transporter rZip10 (Slc39a10) involved in zinc uptake across rat renal brush-border membrane. Am J Physiol Renal Physiol 2007, 292:F217-F229.
48. Clifford KS, MacDonald MJ. Survey of mRNAs encoding zinc transporters and other metal complexing proteins in pancreatic islets of rats from birth to adulthood: similar patterns in the Sprague-Dawley and Wistar BB strains. Diabetes Res Clin Pract 2000, 49:77-85.
49. Valentine RA, Jackson KA, Christie GR, Mathers JC, Taylor PM, Ford D. ZnT5 variant B is a bidirectional zinc transporter and mediates zinc uptake in human intestinal Caco-2 cells. J Biol Chem 2007, 282:14389-14393.
50. Kambe T, Narita H, Yamaguchi-Iwai Y. Cloning and characterization of a novel mammalian zinc transporter, zinc transporter 5, abundantly expressed in pancreatic beta cells. J Biol Chem 2002, 277:19049-19055.
51. Jackson KA, Helston RM, McKay JA, O'Neill ED, Mathers JC, Ford D. Splice variants of the human zinc transporter ZnT5 (SLC30A5) are differentially localized and regulated by zinc through transcription and mRNA stability. J Biol Chem 2007, 282:10423-10431.
52. Inoue K, Matsuda K, Itoh M. Osteopenia and male-specific sudden cardiac death in mice lacking a zinc transporter gene, Znt5. Hum Mol Genet 2002, 11:1775-1784.
53. Sladek R, Rocheleau G, Rung J. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445:881-885.
54. Steinthorsdottir V, Thorleifsson G, Reynisdottir I. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 2007, 39:770-775.
55. Ng MC, Park KS, Oh B. Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6,719 Asians. Diabetes 2008, 57:2226-2233.
56. Borowiec M, Thompson R, Powers C, Xu R, Dickey T, Doria A. Mutations in the SLC30A8 gene are not a major cause of MODY or other forms of early-onset, autosomal dominant type 2 diabetes. Diabetologia 2007, 50:2224-2226.
57. Wenzlau JM, Juhl K, Yu L. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A 2007, 104:17040-17045.
58. Walter M, Kaupper T, Ziegler A, Davidson HW, Wenzlau JM, Hutton JC. The decline in circulating Slc30A8 autoantibodies track falling post-prandial C-peptide responses in the years following type 1 diabetes onset in human subjects. Diabetologia 2007, 50:S64.
59. Brorsson C, Bergholdt R, Sjögren M. A non-synonymous variant in SLC30A8 is not associated with type 1 diabetes in the Danish population. Mol Genet Metab 2008, 94:386-388.
60. Gohlke H, Ferrari U, Koczwara K, Bonifacio E, Illig T, Ziegler AG. SLC30A8 (ZnT8) polymorphism is associated with young age at type 1 diabetes onset. Rev Diabet Stud 2008, 5:25-27.
61. Qu HQ, Grant SF, Bradfield JP. Association analysis of type 2 diabetes Loci in type 1 diabetes. Diabetes 2008, 57:1983-1986.
62. Staiger H, Machicao F, Stefan N. Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function. PLoS One 2007, 2:E832.
63. Kirchhoff K, Machicao F, Haupt A. Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Diabetologia 2008, 51:597-601.
64. Cauchi S, Proenca C, Choquet H. Analysis of novel risk loci for type 2 diabetes in a general French population: the D.E.S.I.R. study. J Mol Med 2008, 86:341-348. D.E.S.I.R. Study Group.
65. Pascoe L, Tura A, Patel SK. Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function. Diabetes 2007, 56:3101-3104. RISC Consortium; U.K. Type 2 Diabetes Genetics Consortium.
66. Ruchat SM, Elks CE, Loos RJ. Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genomewide association studies. Acta Diabetol 2009, 46:217-226.
67. Seve M, Chimienti F, Devergnas S, Favier A. In silico identification and expression of SLC30 family genes: an expressed sequence tag data mining strategy for the characterization of zinc transporters' tissue expression. BMC Genomics 2004, 5:32-40.
68. Chimienti F, Devergnas S, Pattou F. In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion. J Cell Sci 2006, 119:4199-4206.
69. Smidt K, Pedersen SB, Brock B. Zinc-transporter genes in human visceral and subcutaneous adipocytes: lean versus obese. Mol Cell Endocrinol 2007, 264:68-73.
70. Overbeck S, Uciechowski P, Ackland ML, Ford D, Rink L. Intracellular zinc homeostasis in leukocyte subsets is regulated by different expression of zinc exporters ZnT-1 to ZnT-9. J Leukoc Biol 2008, 83:368-380.
71. Murgia C, Devirgiliis C, Mancini E, Donadel G, Zalewski P, Perozzi G. Diabetes-linked zinc transporter ZnT8 is a homodimeric protein expressed by distinct rodent endocrine cell types in the pancreas and other glands. Nutr Metab Cardiovasc Dis 2009, 19:431-439.
72. Egefjord L, Jensen JL, Bang-Berthelsen CH. Zinc transporter gene expression is regulated by pro-inflammatory cytokines: a potential role for zinc transporters in beta-cell apoptosis?. BMC Endocr Disord 2009, 25:7-16.
73. Lu M, Fu D. Structure of the zinc transporter YiiP. Science 2007, 31:1746-1748.
74. Souza SC, Qiu L, Inouye KE, Roix JJ, Chen H. Zinc transporter ZnT-8 regulates insulin and glucagon secretion in Min6 and aTC1-9 pancreatic cell lines. Eur Assoc Study Diabetes 2008
75. Pound LD, Sarkar S, Benninger RK. Deletion of the mouse Slc30a8 gene encoding zinc transporter-8 results in impaired insulin secretion. Biochem J 2009, 421:371-376.